Pro Share Advisors LLC Akouos, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$4.16 - $9.08 $42,040 - $91,762	-10,106 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$7.65 - $11.38 $2,570 - $3,823	-336 Reduced 3.22%	10,106 $86,000
Q3 2021 Nov 12, 2021	SELL	$9.93 - $13.59 $19,611 - $26,840	-1,975 Reduced 15.91%	10,442 $121,000
Q2 2021 Aug 13, 2021	BUY	$11.87 - $15.96 $13,424 - $18,050	1,131 Added 10.02%	12,417 $156,000
Q1 2021 May 14, 2021	BUY	$13.87 - $21.04 $156,536 - $237,457	11,286 New	11,286 $157,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.